Skip to main content
Top
Published in: Diabetologia 8/2015

01-08-2015 | Article

Inverse association between fasting plasma glucose and risk of ventricular arrhythmias

Authors: Francesco Zaccardi, David R. Webb, Sudhir Kurl, Kamlesh Khunti, Melanie J. Davies, Jari A. Laukkanen

Published in: Diabetologia | Issue 8/2015

Login to get access

Abstract

Aims/hypothesis

In nondiabetic individuals, low values of fasting plasma glucose (FPG) have been associated with an increased risk of cardiovascular events. Identification of the potential mechanisms behind this association could help to elucidate the relationship between glycaemia and cardiovascular disease. We aimed to determine the association between FPG and ventricular arrhythmias.

Methods

FPG and other cardiometabolic risk factors were measured in a population-based cohort of 2,482 men without a known history of type 2 diabetes mellitus at baseline. Associations between FPG levels and incident cases of ventricular arrhythmias (ventricular tachycardia or fibrillation events ascertained using the National Hospital Discharge Register) were estimated using Cox regression analysis adjusted for potential confounders.

Results

During a median follow-up of 23.3 (interquartile range 18.5–25.3) years, 74 (2.9%) incident events were recorded. In a multivariable analysis adjusted for age, systolic BP, smoking status, LDL- and HDL-cholesterol, and C-reactive protein, the HR for ventricular arrhythmia per 1 mmol/l higher baseline FPG was 0.58 (95% CI 0.34, 0.98); this estimate did not materially change after further adjustment for BMI, alcohol consumption, triacylglycerols and history of ischaemic heart disease (0.50 [95% CI 0.28, 0.89]).

Conclusions/interpretation

In this nondiabetic male population, FPG was inversely associated with incident risk of ventricular arrhythmias. While our results could help clarify the relationship between low glucose levels and cardiovascular risk, further studies are required to confirm these findings in other populations.
Appendix
Available only for authorised users
Literature
1.
go back to reference Emerging Risk Factors Collaboration, Di Angelantonio E, Gao P et al (2014) Glycated hemoglobin measurement and prediction of cardiovascular disease. JAMA 311:1225–1233CrossRef Emerging Risk Factors Collaboration, Di Angelantonio E, Gao P et al (2014) Glycated hemoglobin measurement and prediction of cardiovascular disease. JAMA 311:1225–1233CrossRef
2.
go back to reference Emerging Risk Factors Collaboration, Seshasai SR, Kaptoge S et al (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364:829–841CrossRef Emerging Risk Factors Collaboration, Seshasai SR, Kaptoge S et al (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364:829–841CrossRef
3.
go back to reference Emerging Risk Factors Collaboration, Sarwar N, Gao P et al (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375:2215–2222CrossRef Emerging Risk Factors Collaboration, Sarwar N, Gao P et al (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375:2215–2222CrossRef
4.
go back to reference DECODE Study Group, European Diabetes Epidemiology Group (2003) Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 26:688–696CrossRef DECODE Study Group, European Diabetes Epidemiology Group (2003) Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 26:688–696CrossRef
5.
go back to reference Wei M, Gibbons LW, Mitchell TL, Kampert JB, Stern MP, Blair SN (2000) Low fasting plasma glucose level as a predictor of cardiovascular disease and all-cause mortality. Circulation 101:2047–2052PubMedCrossRef Wei M, Gibbons LW, Mitchell TL, Kampert JB, Stern MP, Blair SN (2000) Low fasting plasma glucose level as a predictor of cardiovascular disease and all-cause mortality. Circulation 101:2047–2052PubMedCrossRef
6.
go back to reference Wändell PE, Theobald H (2007) The association between low fasting blood glucose value and mortality. Curr Diabetes Rev 3:274–279PubMedCrossRef Wändell PE, Theobald H (2007) The association between low fasting blood glucose value and mortality. Curr Diabetes Rev 3:274–279PubMedCrossRef
7.
go back to reference Zipes DP, Camm AJ, Borggrefe M et al (2006) ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 27:2099–2140PubMedCrossRef Zipes DP, Camm AJ, Borggrefe M et al (2006) ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 27:2099–2140PubMedCrossRef
8.
go back to reference Eckert B, Agardh CD (1998) Hypoglycaemia leads to an increased QT interval in normal men. Clin Physiol 18:570–575PubMedCrossRef Eckert B, Agardh CD (1998) Hypoglycaemia leads to an increased QT interval in normal men. Clin Physiol 18:570–575PubMedCrossRef
9.
go back to reference Chow E, Bernjak A, Williams S et al (2014) Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk. Diabetes 63:1738–1747PubMedCrossRef Chow E, Bernjak A, Williams S et al (2014) Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk. Diabetes 63:1738–1747PubMedCrossRef
10.
go back to reference Nordin C (2010) The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence. Diabetologia 53:1552–1561PubMedCrossRef Nordin C (2010) The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence. Diabetologia 53:1552–1561PubMedCrossRef
11.
go back to reference Skyler JS, Bergenstal R, Bonow RO et al (2009) Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the ADA and a Scientific Statement of the ACC Foundation and the AHA. J Am Coll Cardiol 53:298–304PubMedCrossRef Skyler JS, Bergenstal R, Bonow RO et al (2009) Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the ADA and a Scientific Statement of the ACC Foundation and the AHA. J Am Coll Cardiol 53:298–304PubMedCrossRef
12.
go back to reference Salonen JT (1988) Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Clin Res 20:46–50PubMed Salonen JT (1988) Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Clin Res 20:46–50PubMed
13.
go back to reference von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, STROBE Initiative (2008) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61:344–349CrossRef von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, STROBE Initiative (2008) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61:344–349CrossRef
14.
go back to reference Lakka TA, Venäläinen JM, Rauramaa R, Salonen R, Tuomilehto J, Salonen JT (1994) Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction. N Engl J Med 330:1549–1554PubMedCrossRef Lakka TA, Venäläinen JM, Rauramaa R, Salonen R, Tuomilehto J, Salonen JT (1994) Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction. N Engl J Med 330:1549–1554PubMedCrossRef
15.
go back to reference Laukkanen JA, Mäkikallio TH, Rauramaa R, Kiviniemi V, Ronkainen K, Kurl S (2010) Cardiorespiratory fitness is related to the risk of sudden cardiac death: a population-based follow-up study. J Am Coll Cardiol 56:1476–1483PubMedCrossRef Laukkanen JA, Mäkikallio TH, Rauramaa R, Kiviniemi V, Ronkainen K, Kurl S (2010) Cardiorespiratory fitness is related to the risk of sudden cardiac death: a population-based follow-up study. J Am Coll Cardiol 56:1476–1483PubMedCrossRef
16.
go back to reference Easton DF, Peto J, Babiker AG (1991) Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med 10:1025–1035PubMedCrossRef Easton DF, Peto J, Babiker AG (1991) Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med 10:1025–1035PubMedCrossRef
17.
go back to reference Coutinho M, Gerstein HC, Wang Y, Yusuf S (1999) The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22:233–240PubMedCrossRef Coutinho M, Gerstein HC, Wang Y, Yusuf S (1999) The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22:233–240PubMedCrossRef
18.
go back to reference Balkau B, Bertrais S, Ducimetiere P, Eschwege E (1999) Is there a glycemic threshold for mortality risk? Diabetes Care 22:696–699PubMedCrossRef Balkau B, Bertrais S, Ducimetiere P, Eschwege E (1999) Is there a glycemic threshold for mortality risk? Diabetes Care 22:696–699PubMedCrossRef
19.
go back to reference Levitan EB, Song Y, Ford ES, Liu S (2004) Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 164:2147–2155PubMedCrossRef Levitan EB, Song Y, Ford ES, Liu S (2004) Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 164:2147–2155PubMedCrossRef
20.
21.
go back to reference Zhang Y, Han H, Wang J, Wang H, Yang B, Wang Z (2003) Impairment of human ether-à-go-go-related gene (HERG) K+ channel function by hypoglycemia and hyperglycemia. Similar phenotypes but different mechanisms. J Biol Chem 278:10417–10426PubMedCrossRef Zhang Y, Han H, Wang J, Wang H, Yang B, Wang Z (2003) Impairment of human ether-à-go-go-related gene (HERG) K+ channel function by hypoglycemia and hyperglycemia. Similar phenotypes but different mechanisms. J Biol Chem 278:10417–10426PubMedCrossRef
23.
go back to reference Thygesen K, Alpert JS, Jaffe AS et al (2012) ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Eur Heart J 33:2551–2567PubMedCrossRef Thygesen K, Alpert JS, Jaffe AS et al (2012) ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Eur Heart J 33:2551–2567PubMedCrossRef
25.
go back to reference Kleppe M, Levine RL (2014) Tumor heterogeneity confounds and illuminates: assessing the implications. Nat Med 20:342–344PubMedCrossRef Kleppe M, Levine RL (2014) Tumor heterogeneity confounds and illuminates: assessing the implications. Nat Med 20:342–344PubMedCrossRef
27.
go back to reference ORIGIN Trial Investigators, Mellbin LG, Rydén L, Riddle MC et al (2013) Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial. Eur Heart J 34:3137–3144CrossRef ORIGIN Trial Investigators, Mellbin LG, Rydén L, Riddle MC et al (2013) Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial. Eur Heart J 34:3137–3144CrossRef
29.
go back to reference Seaquist ER, Anderson J, Childs B et al (2013) Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 36:1384–1395PubMedCentralPubMedCrossRef Seaquist ER, Anderson J, Childs B et al (2013) Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 36:1384–1395PubMedCentralPubMedCrossRef
30.
go back to reference Laukkanen JA, Mäkikallio TH, Ronkainen K, Karppi J, Kurl S (2013) Impaired fasting plasma glucose and type 2 diabetes are related to the risk of out-of-hospital sudden cardiac death and all-cause mortality. Diabetes Care 36:1166–1171PubMedCentralPubMedCrossRef Laukkanen JA, Mäkikallio TH, Ronkainen K, Karppi J, Kurl S (2013) Impaired fasting plasma glucose and type 2 diabetes are related to the risk of out-of-hospital sudden cardiac death and all-cause mortality. Diabetes Care 36:1166–1171PubMedCentralPubMedCrossRef
31.
go back to reference John RM, Tedrow UB, Koplan BA et al (2012) Ventricular arrhythmias and sudden cardiac death. Lancet 380:1520–1529PubMedCrossRef John RM, Tedrow UB, Koplan BA et al (2012) Ventricular arrhythmias and sudden cardiac death. Lancet 380:1520–1529PubMedCrossRef
Metadata
Title
Inverse association between fasting plasma glucose and risk of ventricular arrhythmias
Authors
Francesco Zaccardi
David R. Webb
Sudhir Kurl
Kamlesh Khunti
Melanie J. Davies
Jari A. Laukkanen
Publication date
01-08-2015
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 8/2015
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-015-3646-0

Other articles of this Issue 8/2015

Diabetologia 8/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.